z-logo
Premium
Synthesis and Anti‐HIV Activity of [ddN]‐[ddN] Dimers and Benzimidazole Nucleoside Dimers
Author(s) -
Li GuoRui,
Liu Jun,
Pan Qin,
Song ZhiBin,
Luo FengLing,
Wang ShaoRu,
Zhang XiaoLian,
Zhou Xiang
Publication year - 2009
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.200800281
Subject(s) - benzimidazole , chemistry , human immunodeficiency virus (hiv) , nucleoside , nucleoside analogue , stereochemistry , virology , organic chemistry , medicine
In an attempt to combine the HIV‐inhibitory capacity of different 2′,3′‐dideoxynucleoside (ddN) analogs, we have designed and synthesized several dimers of [AZT]‐[AZT] and [AZT]‐[d4T]. In addition, we also synthesized the dimers of 1‐(1 H ‐benzimidazol‐1‐yl)‐1‐deoxy‐ β ‐ D ‐ribofuranose. The in vitro anti‐HIV activity of these compounds on a pseudotype virus, pNL4‐3.Luc.R‐E‐, in the 293T cells has been determined. Among these compounds, 2,2′‐(propane‐1,3‐diyl)bis[1‐( β ‐ D ‐ribofuranosyl)‐1 H ‐benzimidazole] ( 3 ) showed the highest anti‐HIV activity with similar effect as AZT.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom